Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86

Affiliations

¹ Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany. Electronic address: carsten.ohlmann@uks.eu.
² Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany.

Comment

Carsten-Henning Ohlmann et al. Eur Urol. 2015 Dec.

. 2015 Dec;68(6):1104-5.

doi: 10.1016/j.eururo.2015.08.013. Epub 2015 Aug 29.

¹ Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany. Electronic address: carsten.ohlmann@uks.eu.
² Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany.

No abstract available

Comment on

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Clinical Trial.